VERNALIS RES LTD has a total of 235 patent applications. Its first patent ever was published in 1998. It filed its patents most often in United States, EPO (European Patent Office) and United Kingdom. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and environmental technology are PAGE PATRICK, LYSOSOMAL THERAPEUTICS INC and WINSSINGER NICOLAS.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 51 | |
#2 | EPO (European Patent Office) | 29 | |
#3 | United Kingdom | 28 | |
#4 | Canada | 15 | |
#5 | WIPO (World Intellectual Property Organization) | 15 | |
#6 | Australia | 10 | |
#7 | China | 10 | |
#8 | Brazil | 8 | |
#9 | Mexico | 8 | |
#10 | South Africa | 8 | |
#11 | Israel | 6 | |
#12 | Norway | 6 | |
#13 | New Zealand | 5 | |
#14 | Peru | 5 | |
#15 | Argentina | 4 | |
#16 | Republic of Korea | 4 | |
#17 | Czechia | 3 | |
#18 | Hong Kong | 3 | |
#19 | Hungary | 3 | |
#20 | Poland | 3 | |
#21 | Croatia | 2 | |
#22 | Uruguay | 2 | |
#23 | Yugoslavia (Serbia and Montenegro) | 2 | |
#24 | EAPO (Eurasian Patent Organization) | 1 | |
#25 | Indonesia | 1 | |
#26 | Japan | 1 | |
#27 | Serbia | 1 | |
#28 | Taiwan | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Environmental technology |
# | Name | Total Patents |
---|---|---|
#1 | Adams David Reginald | 80 |
#2 | Davidson James Edward Paul | 62 |
#3 | Gaur Suneel | 60 |
#4 | Gillespie Roger John | 60 |
#5 | Mansell Howard Langham | 58 |
#6 | Roffey Jonathan Richard Anthon | 50 |
#7 | Lerpiniere Joanne | 50 |
#8 | Hamlyn Richard John | 47 |
#9 | Bentley Jonathan Mark | 42 |
#10 | Dawson Claire Elizabeth | 41 |
Publication | Filing date | Title |
---|---|---|
GB0504324D0 | Bicyclic fused pyrimidine compounds | |
NZ543322A | The use of azetidinecarboxamide derivates in therapy | |
WO2004096794A1 | Azetidinecarboxamide derivatives and their use in the treatment of cb1 receptor mediated disordrs | |
BRPI0409938A | azetidinecarboxamide derivatives and their use in therapy | |
GB0403155D0 | Chemical compounds | |
GB0209987D0 | Screening method and method of treatment | |
GB0206698D0 | Screening method and method of treatment | |
GB0206699D0 | Method of treatment | |
GB0202872D0 | Screening method and method of treatment | |
GB0202408D0 | Chemical compounds XXIII | |
GB0202161D0 | Chemical compounds V | |
GB0201281D0 | Method of treatment | |
GB0201280D0 | Screening method and method of treatment | |
GB0126302D0 | Chemical compounds III | |
GB0126300D0 | Chemical compounds - H | |
GB0126301D0 | Chemical compounds - I | |
GB0119838D0 | Chemical compounds (R3) | |
GB0119837D0 | Chemical compounds (R4) | |
GB0118892D0 | Method of treatment | |
CA2415585A1 | 2-adamantylethylamines and their use in the treatment of conditions generally associated with abnormalities in glutamatergic transmission |